Photo: Göran Assner
XXXIV Nordic Congress
in Clinical Chemistry
September 16 – 19, 2014 at Svenska Mässan in Göteborg
Final Programme
www.nfkk2014.se
Nordisk Forening for Klinisk Kemi
SKKLF
Sveriges klinisk kemiska
laboratorieingenjörers förening
C: 88
M: 0
Y: 57
K: 36
Contents
Welcome............................ 1
Committees......................... 2
Scientific Program, Overview...... 4
Scientific Program, Day by Day.... 7
Posters list. . ....................... 13
Author index. . .................... 18
Guidelines for Speakers.......... 24
Social Program. . .................. 26
Congress Information............ 27
General Information. . ............ 28
Our Exhibitors. . ................... 34
City Map.......................... 36
Dear NCCC Delegates
It is a pleasure and a privilege to welcome you to Gothenburg, Sweden, for
the XXXIVth Nordic Congress in Clinical Chemistry on September 16 –19, 2014.
A major aim of the NCCC 2014 is to gather all professions in the clinical labs
in the Nordic countries, to meet, discuss and share knowledge. Another aim is to
broaden our perspective with the overall theme of ”Future opportunities in clinical
chemistry”. This includes exciting examples of how the laboratory with its expertise
among physicians, biomedical scientists, chemists and laboratory engineers can
develop further as a diagnostic partner. The meeting will also cover the use of new
biomarkers in risk assessment and diagnosis, novel areas of biomarker discovery,
including glycoproteomics, tissue-specific inflammation and an interesting example
of using biomarker patterns in multivariate analysis. We will also learn about
emerging laboratory techniques, including Next Generation Sequencing and single
molecule detection.
We wish to extend a cordial welcome to Gothenburg to all of you, and we
hope that, during this meeting and especially at the spectacular Glitter & Glamour
banquet on the 18th of September, you will meet old friends, make new friends
and establish important future connections with colleagues throughout the
Nordic countries.
On behalf of the organizing committee I wish
you all VERY WELCOME to Gothenburg!
Ola Hammarsten
President, XXXIV Nordic Congress
in Clinical Chemistry
1
Committees
Organising Committee
Ola Hammarsten, Chairman of the Scientific Committee for The XXXIVth Nordic
Congress in Clinical Chemistry, MD, PhD, Professor, Senior Consultant, Clinical
Chemistry, Sahlgrenska University Hospital
Birgitta Kallberg, Head of Unit Clinical Chemistry, Sahlgrenska University Hospital/Mölndal
Camilla Brantsing, Biomedical Scientist, Section leader at Clinical molecular
research, Clinical Chemistry, Sahlgrenska University Hospital
Therese Lorentzon Gräbel, Head Secretary, Clinical Chemistry, Sahlgrenska
University Hospital
Scientific Committee
Ola Hammarsten, Chairman of the
­Scientific Committee for The XXXIVth
­Nordic Congress in Clinical Chemistry, MD,
PhD, Professor, Senior Consultant, Clinical
Chemistry, Sahlgrenska University Hospital
Jorge Asin Cayuela, MD, PhD, Associate
Professor, Clinical Chemistry, Sahlgrenska
University Hospital
Julia Asp, PhD, Associate Professor, Clinical
Chemistry, Sahlgrenska University Hospital
Anders Elmgren, MD, PhD, Clinical
­Chemistry, Sahlgrenska University Hospital
Linda Fogelstrand, MD, PhD, Clinical
Chemistry, Sahlgrenska University Hospital
2
Stefan Jacobsson, MD, Senior Consultant
Clinical Chemistry, Sahlgrenska University
Hospital
Anne-Marie Johannesson, POCT
­Coordinator, Biomedical Scientist, Clinical
Chemistry, Sahlgrenska University Hospital
Helene Johansson, President, The Swedish
Institute of Biomedical Laboratory Science,
Regional Quality coordinator for haematologi­
cal diagnostics in Västra Götaland, Clinical
Chemistry, Sahlgrenska University Hospital
Göran Larson, MD, PhD, Professor,
Senior Lecturer, Clinical Chemistry,
­Sahlgrenska University Hospital
Anders Larsson, MD, PhD, Professor and
Consultant, Clinical Chemistry, Akademiska
Hospital, Uppsala
Lars Palmqvist, MD, PhD, Associate
­Professor, Senior Consultant, Clinical
Chemistry, Sahlgrenska University Hospital
Anders Lindahl, MD, PhD, Professor, Clinical
Chemistry, Sahlgrenska University Hospital
Anne Ricksten, PhD, Associate Professor,
Clinical Chemistry, Sahlgrenska University
Hospital
Christian Löwbeer, MD, PhD, Clinical
Chemistry, Aleris Medilab
Mats Ohlson, PhD, Clinical Chemistry,
Sahlgrenska University Hospital, President
of The Swedish Association of Clinical
­Biochemists
Henrik Zetterberg, MD, PhD Professor of
Neurochemistry, Senior Consultant in Clinical
Chemistry, Sahlgrenska University Hospital
Conference Organisation
Conference organisation, registration and abstract management,
sponsoring and exhibition.
Congress secretariat
Delegate service, housing, social programme
MCI – Gothenburg Office
Mail: confirmation@mci-group.com
Phone: + 46 (31) 780 30 30
www.mci-group.com
Congress venue
The Swedish Exhibition & Congress Centre (Svenska Mässan)
Mässans Gata 2, Gothenburg, Sweden
3
Scientific Program Overview
Tuesday, September 16
Room:
11:00
Registration
13:20
Opening Ceremony
F3
13:30
Afternoon Session: Food, metabolomics and health
F3
15:15
Welcome Reception in the exhibition hall
Wednesday, September 17
08:00 – 08:45
Breakfast seminar: Beckman Coulter AB
F1
09:00
Morning Plenary session:
Future biomarkers in acute coronary syndromes
F3
09:45
Coffee and exhibition in the exhibition and poster area
10:15
Biomarkers for future risk of cardiovascular disease
F1
10:15
Laboratory Point Of Care Testing – current and future
­challenges
F2
10:15
Novel laboratory technology – the single ­molecule era
F3
12:00
Lunch – Exhibition and lunch seminars
12:30–13:15
Abbott Scandinavia AB
F1
12:30–13:15
Siemens Healthcare Diagnostics
F2
14:00
Afternoon Plenary session:
Surface-based single-liposome sensing for diagnostics and drug
screening applications
F3
14:45
Coffee and exhibition in the exhibition and poster area
15:15
Novel diagnostic biomarkers in cardiology
F1
15:15
The Astrup Prize
F2
15:15
Next Generation Sequencing (NGS) in clinical diagnosis
F3
16:00
SKKLF Annual Meeting
Nordensköld
16:45
SSKF Annual ­Meeting
F3
Possibility for companies to arrange a social sponsor a
­ ctivity
4
Thursday, September 18
Room:
08:00 – 08:45
Breakfast seminar: HemoCue
F2
08:00 – 08:45
Breakfast seminar: Thermo Fisher Scientific
F1
09:00
Morning Plenary session: Vitamin B12 deficiency
New trends in biomarkers and diagnostic ­strategies
F3
09:45
Coffee and exhibition in the exhibition and poster area
10:15
Rare disorders of erythrocytes. The dysregulation of iron
and ferritin h
­ omeostasis
F1
10:15
Biomarkers in diagnosis of neurodegenerative diseases
F2
10:15
The future clinical laboratory as a diagnostic partner
F3
12:00
Lunch – Exhibition and lunch seminars
12:30–13:15
Roche Diagnostics AB
F1
12:30–13:15
Sysmex Sverige
F2
14:00
Afternoon Plenary session: Blood based biomarkers for
­Alzheimer’s disease – from case control to endophenotype
discovery and from small to large, potentially huge, replication
F3
14:45
Coffee and exhibition in the exhibition and poster area
15:15
Laboratory diagnostics of myeloproliferative neoplasms
F1
15:15
The Eldjarn Prize
F2
15:15
Organization of the future clinical laboratory
F3
16:45
SFKK Annual Meeting
F1
19:30
Banquet “Glitter and Glamoure” in Estrad Restaurant
Friday, September 19
09:00
Morning Plenary session: Application of massively parallel
sequencing (MPS) for clinical analyses: challenges and opportunities
F3
09:45
Coffee and exhibition in the exhibition and poster area
10:15
Clinical laboratory education today and tomorrow
F1
10:15
Future use of cancer biomarkers
F2
10:15
Biomarkers of kidney disease
F3
12:00
Poster Prize winning ceremony and Closing Remarks
F3
5
ARCHITECT STAT HIGH SENSITIVE
TROPONIN-I ASSAY
Redefining Precision
to Increase Confidence in
Decision Making for Chest
Pain in the Acute Setting
Hear more at our
Lunch Symposium
Wednesday, September 17th, 12.30-13.15, Room F1
or come to the Abbott Booth
6
www.abbott.com
ADD-00003721
Scientific Program,
day by day
Tuesday, September 16
07:00
Exhibition building up and moving in 07:00–10:00
11:00
Registration
13:20 –
13:30
Opening Ceremony Room: F3
Opening of the XXXI V Nordic Congress in Clinical Chemistry by the President Ola Hammarsten
13:30 –
15:00
Afternoon session: Food, metabolomics and health Room: F3
Metabolites and antioxidants from dietary sources or produced endogenously are becoming an important
field of study to find new biomarkers for disease. This session will discuss recent developments in the
study of the human metabolome, inflammation and the role of antioxidants in health and disease
Chair: Ola Hammarsten
13:30 –14:00 Clinical Metabolomics: the next stage of clinical biochemistry? (101)
Jan Borén, Sweden
14:00 –14:30 Can we tell infection from tissue damage as a cause of inflammation? A strategy
using clinical chemistry and patten recognition methods (102)
Agnes Wold, Sweden
14:30–15:00 Antioxidants – the dark side (103)
Per Lindahl, Sweden
15:15
Welcome Reception in the exhibition hall
The reception is hosted by the City of Göteborg and the Region of Västra Götaland.
7
Wednesday, September 17
08:00 –
08:45
Breakfast seminar: Beckman Coulter AB Room: F1
Beckman Coulter’s Innovative Approach to Automating Clinical Molecular Diagnostics
Speaker: Brendan McKeown, PhD, Senior Molecular Applications Specialist, UK
09:00
Morning Plenary session Room: F3
Chair: Ola Hammarsten
Future biomarkers in acute coronary syndromes (201)
Bertil Lindahl, Sweden
09:45
Coffee and exhibition in the exhibition and poster area
10:15
Parallel Sessions
Room F1:
Biomarkers for future
risk of cardiovascular disease
Our ability to use biomarkers
to predict the development of
cardiovascular disease in a healthy
person, as a foundation for primary
prevention, is currently less than
perfect. This session will discuss
approaches to finding new biomarkers that may be used for primary and secondary prevention
Chairs: Ola Hammarsten and
­Christian Löwbeer
10:15 –10:45 Endocrine and
metabolic risk factors for cardio­
metabolic disease (202)
Olle Melander, Sweden
10:45 –11:15 Novel and established kidney disease biomarkers
in the prediction of cardio­
vascular disease (203)
Johan Ärnlöv, Sweden
11:15 –11:45 Risk prediction of
­cardiovascular disease by high
sensitive cardiac troponin assays
(204)
Per Venge, Sweden
11:45–12:00 Integrated Targeted
Quantitation Method for Insulin
and its Therapeutic Analogs (205)
Ravindra Chaudhari,
United States
Room F2:
Laboratory Point Of Care
Testing – current and future
challenges
Small and locally available
laboratory equipment gives
the physician convenient
and immediate access to
test results. However, as the
tests are often performed by
untrained personnel, the test
quality is often a problem.
This session will discuss the
current and future challenges
in the quality control of Point
Of Care Testing
Chair: Anne-Charlotte
­W icktorsson
10:15–10:25 Introduction
10:25–10:55 Patient safety –
the value of SKUP evaluations
of point of care instruments
(206)
Elisabeth Eriksson Boija,
­Sweden
10:55–11:25 Quality assurance
of the pre- and post analytical
phase (207)
Sverre Sandberg, Norway.
11:25–11:55 Accreditation of
Point Of Care Testing, POCT,
at Sahlgrenska University
­Hospital according to ISO
22870:2006 (208)
Birgitta Kallberg, Sweden
11:55–12:00 Summary
12:00
8
Lunch – Exhibition and lunch seminars
Room F3:
Novel laboratory technology
– the single molecule era
Nanotechnology and other techniques
now allow reliable single molecule
detection that can be implemented in
routine analysis. This session will cover
the challenges and opportunities that
this novel technology will bring to
clinical laboratories
Chairs: Julia Asp and Göran Larson
10:15–10:45 Analyzing biology cell
by cell and molecule by molecule (209)
Ulf Landegren and
Masood Kamali-Moghaddam
10:45–11:15 High throughput single cell
expression profiling and characterization
of circulating tumor cells (210)
Mikael Kubista, Sweden
11:15–11:40 A translational equine
approach towards development of
human biomarkers of early osteoarthritis
(211)
Anders Lindahl, Sweden
11:40–11:50 Establishment of a GC-MS/
MS methodology for comprehensive sex
steroid profiling in mouse serum (212)
Maria Nilsson, Sweden
11:50–12:00 Development and
­appli­cation of an LC-MS method
with high resolution accurate masses
­detection (HRAM) with ExactivePlus
mass ­spectrometer and online sample
preparation (213)
Valérie Thibert, France
12:30 –
13:15
Lunch seminars:
Abbott Scandinavia AB Room: F1
Chairperson: Dave Ambruster, Director, Global Scientific Affairs, Abbott Diagnostics
Real life experiences of new assays. HbA1c multicentre study- what do the results tell us
Speaker: Johannes Lotz, Institute for Laboratory Medicine, University Hospital Mainz, Germany
Our experience with High Sensitive Troponin
Speakers: Clare Ford, The Royal Wolverhampton NHS Trust, New Cross Hospital, UK
12:30 –
13:15
Siemens Healthcare Diagnostics Room: F2
Elf in Liver Fibrosis
Speaker: Professor W M C Rosenberg MA, MBBS, DPhil, FRCP, UCL Institute for Liver & Digestive
Health, University College, UK
14:00
Afternoon Plenary session Room: F3
Chair: Göran Larson
Surface-based single-liposome sensing for diagnostics and drug screening applications (214)
Fredrik Höök, Sweden
14:45
Coffee and exhibition in the exhibition and poster area
15:15
Parallel Sessions
Room F1: Novel diagnostic
­bio­markers in cardiology
Room F2: The Astrup
Prize
Room F3: Next Generation Sequen­cing
(NGS) in clinical diagnosis
A large proportion of patients
seeking health care have cardiac
disease that can often be treated
effectively if correctly diagnosed.
This session will discuss novel
diagnostic biomarkers in acute
cardiac care
Chairs: Ola Hammarsten and
­Christian Löwbeer
The Astrup Prize is awarded
to contemporary Nordic
research work related to the
field of clinical chemistry.
The Prize is sponsored by
Siemens.
The winners of the Astrup
prizes will be announced at
the Congress Banquet
Chair: Lars Melholt
­Rasmussen
Next Generation Sequencing has revolutionised
gene sequencing by allowing the simultaneous
analysis of multiple genes, and has been optimised to such an extent that it is now possible
to apply it to clinical diagnoses. In this session
we will present some examples of how NGS
has contributed to the identification of new
gene defects linked to hereditary human
diseases
Chair: Jorge Asin Cayuela and
Anne Ricksten
15:15–15:35 The soluble
­mannose receptor
Sidsel Rødgaard-Hansen,
­D enmark
15:15–15:40 Next generation sequencing
in the identification of new pathogenic
­mechanisms for mitochondrial disorders (219)
Henna Tyynismaa, Finland
15:35–15:55 Comparing
the diagnostic accuracies of
CSF A and PET Flor­betapir
Niklas Mattson, Sweden
15:40–16:05 Next Generation Sequencing
in Inherited Cardiovascular Diseases (220)
Lorenzo Monserrat, Spain
15:15–15:45 Copeptin-Marker
of Acute Myocardial Infarction
(215)
Martin Möckel, Germany
15:45–16:15 PEA multiplex
technology – New tools for
­clinical proteomics (216)
Agneta Siegbahn, Sweden
16:15–16:30 A Multi-Center
­Analytical Evaluation of
the A
­ RCHITECT STAT High
Sensitive Troponin-I Assay (217)
Lieselotte Lennartz, Germany
16:30–16:45 Highly Multiplexed Proteomic Analysis as a
translational tool: Implications
for useful biomarker discovery
and early ­clinical development
(218)
Stephen Williams,
United States
16:00
16:45
15:55–16:15 Detection
of polymerized C1-inh in
plasma of HAE patients
– possible role in contact
activation
Daniel Elenius Madsen,
Denmark
16:05–16:30 Genomic analysis of
­Neurodegenerative Disease (221)
John Hardy, United Kingdom
16:30–16:45 Pilot study for the
detection of mutations associated with­
lysosomal ­diseases using Next Generation
Sequencing (222)
Julia Lindgren, Sweden
16:45–17:00 The use of design programs
from Sequenom when diagnosing familial
hypercholesterolemia (223)
Peter Benedek, Sweden
SKKLF Annual Meeting Room: Nordenskiöld
SSKF Annual Meeting Room: F2
Possibility for companies to arrange a social sponsor activity
9
Thursday, September 18
Breakfast seminars:
08:00–
08:45
Thermo Fisher Scientific Room: F1
Copetin – a marker of risk stratification and for early rule out in patients with suspected ACS
Speaker: Dr. Joern Ole Vollert, MD., Medical Director, Thermo Fisher Scientific
The latest news in molecular allergology
Speaker: Robert Moverare, Principal Scientist, Thermo Fisher Scientific
08:00 –
08:45
HemoCue Room: F2
Improved workflow for efficient emergency healthcare
Speaker: Younis Khalid, Chief Physician, Head of Section, Children’s ER,
Drottning Silvias child- and youth hospital
09:00
Morning Plenary session Room: F3
Chair: Stefan Jacobsson
Vitamin B12 deficiency. New trends in biomarkers and diagnostic strategies (301)
Ebba Nexø, Denmark
09:45
Coffee and exhibition in the exhibition and poster area
10:15
Parallel Sessions
Room F1:
Rare disorders of erythrocytes. The dys­
regulation of iron and ferritin homeostasis
Room F2:
Biomarkers in diagnosis of
neurodegenerative diseases
Dysregulation of the fine-tuned systemic and/or
local iron homeostasis is emerging as an under­
lying cause of haematological and neurodegenerative diseases. Various forms of hereditary
hemochromatosis with low hepcidin expression
and iron-refractory iron deficiency anaemia with
high hepcidin expression are attributed to mutations affecting the hepcidin-mediated control of
the regulation of ferroportin. This session will give
an overview of the molecular mechanisms behind
rare hereditary disorders of the red blood cell.
The aim is to achieve a better understanding of
how to use the different available diagnostic tools
Chairs: Linda Fogelstrand and Stefan Jacobsson
Neurodegenerative disorders
constitute a pleiotropic group
of diseases that are often hard
to distinguish from one another,
without knowledge of the under­
lying pathology, as they often
present with similar symptoms.
This session will focus on the
research frontier of the use of
novel biomarkers in the diagnosis
of neurodegenerative disorders
Chair: Henrik Zetterberg
10:15–10:45 Hereditary hemochromatosis
and ferroportin disease (302)
Sandro Altamura, Germany
10:45–11:15 Neurological disorders of iron
homeostasis: neurodegeneration with brain iron
accumulation (NBIA) and neuroferritinopathies
(303)
Paolo Arosio, Italy
11:15–11:45 Why do we make mistakes in the
morphological interpretation of blood slides
and how can we improve? (304)
John Burthem, United Kingdom
11:45–12:00
Bloodhound Technology™ – Returning to
the roots of Hematology (305)
Mark Fellmann, Switzerland
12:00
10
10:15–10:45 CSF and plasma
biomarkers for Alzheimer’s
­disease – use for diagnostics
and ­theragnostics (306)
Kaj Blennow, Sweden
10:45–11:15 Emergening
molecular diagnostics tools for
Alzheimer’s (AD) and other
neurodegenerative diseases
(307)
Niels H. H. Heegaard, ­
Denmark
11:15–11:45 Single Molecule
Arrays (Simoa) for Ultrasensitive,
Multiplexed Detection of
­Proteins and Nucleic Acids (308)
David Hanlon, United States
Lunch – Exhibition and lunch seminars
Room F3:
The future clinical
l­aboratory as a
­diagnostic ­partner
The expansion of our
knowledge of disease
mechanisms and novel
biomarkers is expected
to increase the interaction
between experts in the
clinical laboratory and
physicians. This session
will discuss what will
be expected from the
laboratoryas a diagnostic
partner in future medicine
Chair: Per Simonsson and
Birgitta Kallberg
10:15–10:40 The
­Cinderellas of health care
(309)
Mirja Mindemark,
­Sweden
10:40–11:05 The future
clinical laboratory as
­diagnostic partner (310)
Martina Jürs, Denmark
11:05-11:30
Do you read me? – Radio
check for clinical ­chemists.
(311)
Per Simonsson, Sweden
12:30–
13:15
Lunch seminars:
Roche Diagnostics AB Room: F1
Panel discussion: True value of labs within the healthcare system
Speakers: Tor-Arne Hagve, Physician Medical biochemistry, Laboratory Medical Centre, Akershus, Oslo.
Göran Larson Professor, Head of Core Facilities Sahlgrenska Akademin. Robert Sinclair MD, Ph.D, DTM&H,
Senior Medical Advisor, Dept. of Health Care Region Västra Götaland. Srinivas Uppugunduri Professor,
Head of Dept. of Clinical Chemistry, Östergötland. Kasper Iversen Ph.D, MD, Cardiologist Head Physician,
Kardiologisk afdeling, Herlev. Magnus Göransson General Manager, Roche Diagnostics, Sweden.
12:30 –
13:15
Sysmex Sverige Room: F2 Better staining. Better diagnostic morphology. Three Ways
Speaker: Henricus Jansen, Marketing Diagnostic Concepts & Lab Solutions, Sysmex Europe
14:00
Afternoon Plenary session Room: F3
Chair: Henrik Zetterberg
Blood based biomarkers for Alzheimer’s disease – from case control to endophenotype discovery
and from small to large, potentially huge, replication (312) Simon Lovestone, United Kingdom
14:45
Coffee and exhibition in the exhibition and poster area
15:15
Parallel Sessions
Room F1: Laboratory diagnostics of myelo­
proliferative neoplasms
Our understanding of the molecular changes
that lead to the development of different myeloproliferative neoplasms (MPN) has developed
rapidly, through the discovery of activating
mutations in several genes responsible for the
regulation of cell differentiation and proliferation
(e.g. the JAK2 gene but also, very recently, the
CALR gene). This has led to new diagnostic
and therapeutic opportunities but also to new
challenges. This session will give a background
and update of the laboratory diagnostic of MPN
and suggestions on how to integrate new genetic
findings in diagnostic algorithms
Chairs: Linda Fogelstrand and Lars Palmqvist
15:15–15:45 Perspectives on chronic inflammation in essential thrombocythemia, polycythemia
vera, and myelofibrosis: is chronic inflammation a
trigger and driver of clonal evolution and development of accelerated atherosclerosis and second
cancer? (313)
Hans Hasselbalch, Denmark
15:45–16:15 Laboratory Diagnostics of Myelo­
proliferative Neoplasms (314)
Susanne Schnittger, Germany
16:15–16:30 Frequency of CALR mutations and
correlation with laboratory findings and clinical
outcome in Essential Thrombocythaemia and
­Primary Myelofibrosis patients (315)
Julia Asp, Sweden
16:30–16:45 European JAK2V617F interlaboratory
quality control study carried out by the
MPN&MPNR-­EURONET (COST ACTION BM0902)
(316) Niels Pallisgaard, Denmark
Room F2: The Eldjarn Prize
The Lorentz Eldjarn Prize
Competition is financed by a
Fund established by Professor
Lorentz Eldjarn and his wife
Torunn in 2009, to reward
the best article published in
Scand J Clin Lab Invest during
the five years preceding the
prize year. The Prize Committee
has nominated three articles
based on the scientific quality
of the studies and the clarity
of the presentations. The
recipients of the prize will be
announced at the Congress
banquet
Chair: Jens P Berg
15:15–15:40 Vitamin D
and PTH – ­seasonal and
age-related variations (317)
Monika Christensen, ­N orway
15:40–16:05 Biomarkers
of alcohol use and related
health risks (318)
Onni Niemelä, Finland
16:05–16:30 Soluble CD163
– a biomarker of macrophage
activation in disease (319)
Holger Jon Møller, Denmark
Room F3: Organisation
of the future clinical
laboratory
As laboratory medicine
has converged during
the past decade, it now
possible to merge several
aspects of the clinical
laboratory. This merger
will need different IT
solutions for different
platforms. This session
will discuss opportunities
and potential problems
in this process
Chairs: Birgitta Kallberg
and Anders Lindahl
15:15–15:35 Opportunities and pitfalls when
­integrating laboratory
­disciplines (320)
Andreas Matussek,
­Sweden
15:35–15:55
The future of Lab
­M edicine seen through
the eyes of a Niche
­Supplier (321)
Jørgen Viktil, Norway
15:55–16:15 Clinical
Chemistry towards the
future-where to go? (322)
Anders Lindahl, Sweden
16:15–16:30
Panel ­discussion
16:45–17:00 SFKK Annual Meeting Room: F1
19:30 Banquet “Glitter and Glamour” Estrad Restaurant, Mässans gata 5. Entrance 5
11
Friday, September 19
09:00
Morning Plenary session Room: F3
Chair: Anne Ricksten
Application of massively parallel sequencing (MPS) for clinical analyses: challenges and opportunities (401)
Ulf Gyllensten, Sweden
09:45 Coffee and exhibition in the exhibition and poster area
10:15
Parallel Sessions
Room F1: Clinical laboratory
education today and tomorrow
Room F2: Future use of
­cancer biomarkers
Room F3: Biomarkers of kidney
disease
The different professions within
laboratory medicine complement
each other. The education programs
are under development and revision.
Future laboratory medicine will
be dynamic with new biomarkers
and techniques. This session will
illustrate the situation within the
Nordic countries
Chairs: Mats Ohlson and
Camilla Hesse
Our knowledge of how cancer
develops and evolves into
stable tissue has recently been
rewritten. In addition, several
cancer biomarkers are now
used for screening and to guide
personalised treatment. This
session will give an overview
of our new vistas in cancer
biology and provide examples
of future cancer biomarkers
that will aid in the diagnosis
and treatment of cancer
Chairs: Julia Asp and Anne
Ricksten
How to estimate kidney function has
been debated for decades. Recently,
ways to standardise the measurement
of cystatin C have been presented, and
new better formulae for both creatinine
and cystatin C-based estimations of the
GFR have been developed. This session
will discuss how kidney function should
be measured. In addition, novel methods
for the measurement of carbohydrate
urine markers and how cardiac markers
might be affected by kidney function
will be discussed
Chairs: Ola Hammarsten and
Anders Larsson
10:15–10:45 Do you think
(cancer) medicine is modern?
The need for a new cancer­
paradigm (407)
Ingemar Ernberg, Sweden
10:15–10:45 Biomarkers of
Kidney Disease (411)
Anders Grubb, Sweden
10:15–10:30 Collaborative Design
of Educational Model for Clinical
Biochemists in Swedish Laboratory
Medicine – “The Swedish Model”
(402)
Tom M Pettersson, Sweden
10:30–10:40 Training of Clinical
Biochemists in Finland (403)
Päivi Laitinen, Finland
10:40–10:55 Biomedical
­laboratory science, present and
future aspects on the education
(404)
Camilla Hesse, Sweden
10:45–11:15 Combined
assessment of six Tumor
­Markers for the Diagnosis
and Histological Diagnosis
of Lung Cancer (408)
Rafael Molina, Spain
10:55–11:05 Clinical laboratory
education today and tomorrow
– the Swedish physician’s
­perspective (405)
Christian Löwbeer, Sweden
11:15–11:45 Biomarkers
increase survival in ovarian
­cancer (409)
Karin Sundfeldt, Sweden
11:05–11:20 Specialist training
in the Nordic Countries and the
­Danish model (406)
Nete Hornung, Denmark
11:20–11:30
Panel discussion
12:00
12
11:45–12:00 Elevated plasma
Cobalamin Predicts a Poor
­Survival for Cancer Patients –
a Population-based Cohort
Study (410)
Johan Frederik Berg Arendt,
Denmark
10:45–11:15 Simple protocol for
preparation and nLC-MS/MS characterization of proteoglycan linkage
region glycopeptides of human
plasma, urine and cerebrospinal
fluid samples (412)
Göran Larson, Sweden
11:15–11:25 Cystatin C-based GFR is
more closely associated with mortality
than creatinine-based GFR in un­selected
patients seeking health care (413)
Johanna Helmersson-Karlqvist,
­Sweden
11:15–11:35 Troponin I levels are less
dependent on glomerular filtration
rate compared to Troponin T and
other cardiac biomarkers (414)
Christian Bjurman, Sweden
Poster Prize winning cermony and Closing Remarks Room: F3
Posters list
Biomarkers in heart disease
P01
Lipoprotein(a), total/HDL-cholesterol ratio, ApoB/ApoA ratio as risk factors for
atherogenesis in patients with coronary artery disease
Danica Labudovic, Sonja Alabakovska, Katerina Tosheska Trajkovska, Jasna Bogdanska,
Silvana Jovanova
P02
High Sensitive Troponin in patients with Erectile Dysfunction
Gianvico Melzi D’eril, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi,
­Massimiliano M. Corsi Romanelli, Alessandra Barassi
P03
Acute pancreatitis and myocardial damage
GianVico Melzi d’Eril, Raffaele Pezzilli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli,
­Alessandra Barassi
P04
Quality assurance measurement of the cholesterol markers apolipoproteins A1 and B;
Going against the grain
Joannis Kinalis, Eva Fahlen, Erika Langenstam, Erika Karabasic
P05
Evaluation of the Alere NT-proBNP test for point of care testing
Banafsheh Seyyed Khezri, Lena Carlsson, Anders Larsson
P06
Serial Troponin T testing based on stored samples in the clinical laboratory
Oscar Oliva Torstensson, Carina Gustafsson, Birgitta Gren, Jan Friden, Ola Hammarsten
P07
Implementation of cardiac biomarkers in ambulatory emergency medicine department
Vaike Viia
P07:2
Estimation of the possible economic effects of a sequential testing strategy with
NT-proBNP before echocardiography in primary care
Banafsheh Seyyed Khezri, Johanna Helmersson-Karlqvist, Anders Larsson
Novel techniques
P08
An invitro assay to measure cell sensitivity to ionizing radiation
Sherin Mathew, Pegah Johansson, Ola Hammarsten
P09
An improved high performance liquid chromatography-fluorescence detection method for
the analysis of Pimozide in human plasma samples
Alessandra Barassi, Francesca Ghilardi, Alessandra Flaminio, Roberta Marotta, GianVico Melzi d'Eril
P10
Validation of a new OptiScanner™ 5000 system for an intermittent glucose monitoring
Alessandra Barassi, Michele Umbrello, Clara A. L. Damele, Francesca Ghilardi, Rossana Stefanelli,
Gaetano Iapichino, GianVico Melzi d'Eril
P11
Preparation and in vitro evaluation of doxorubicin-loaded Fe3O 4 magnetic nanoparticles
modified with biocompatible copolymers
Abolfazl Akbarzadeh
P012
Amyloidosis diagnosis by mass spectrometry
Jakob C. Albrethsen, Morten Salomo, Anders H. Johnsen
13
Biomarkers in neurodegenerative disease
P13
Plasma levels of apolipoprotein E and risk of dementia in the general population
Katrine Laura Rasmussen, Anne Tybjærg-Hansen, Børge G. Nordestgaard, Ruth Frikke-Schmidt
P14
Blood biomarkers for brain injury in concussed professional ice hockey players
Pashtun Shahim, Gisela Malmgård, David H. Wilson, Jeffrey Randall, Birgitta Kallberg,
Yelverton ­Tegner, Kaj Blennow, Henrik Zetterberg
P15
Biomarker-determined Alzheimer prevalence in patients undergoing surgery due to
hip ­fracture
Maria Lönnquist, Birgitta Kallberg, Kaj Blennow, Henrik Zetterberg, Bengt Nellgård
Laboratory as a diagnostic partner
14
P16
Critical results for community based patients and audit of a two tier biochemical phone list
Jeffrey Barron, Geoff Smith
P017
HbA1c as the diagnostic criterion for diabetes reduces incidence and prevalence of DM2
by 25% but strongly depending on analytical quality
Ivan Brandslund, Aneta A. Nielsen, Per H. Petersen, Anders Green, Cramer K. Christensen,
Henry Christensen
P018
Ensuring faster patient treatment by reducing turn-around-time for laboratory results
Carsten Thomsen, Claus Brasen, Christian U. Maegaard, Nina Mogensen, Ivan Brandslund
P019
Vitamin D in patients with pancreatic diseases
Gianvico Melzi D’eril, Alessandra Barassi, Raffaele Pezzilli
P20
Vitamin D and Erectile Dysfunction
Alessandra Barassi, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi,
­Massimiliano M. Corsi Romanelli, GianVico Melzi d’Eril
P21
Assessing the mitochondrial iron metabolism in hereditary hemochromatosis
Sonia Distante, Ragnhild Skinnes, Kari Høie, Lars Mørkrid, Lars Eide
P22
The Role of Early Evaluation of Porphyrins in Diagnosis of Acute Porphyria
Galina Zemtsovskaja, Agnes Ivanov, Marika Pikta
P23
Can Morning Serum Cortisol Ranges and Action Limits be Harmonised?
Robert Wardrop, Narelle Hadlow
P24
An Alpha-Thalassemia Case in Estonia
Marika Pikta, Galina Zemtsovskaja, Iige Viigimaa, Jelena Jerjomina
P25
Use of Pyrosequencing for the Detection of Several Polymorphisms Associated with
Lactase Persistence
Catherine Herrera, Gunnhild Kravdahl, Malene Nilsen
Biomarker development
P26
Effect of fasting on plasma levels of 7-alpha-hydroxy-4-cholesten-3-one – a marker for
bile acid synthesis in humans
Magnus Axelson, Kerstin Brismar
P27
Detection of antinuclear antibodies – a comparison of indirect immunefluorescence on
HEp-2 cells and fluoroenzymeimmunoassay (EliA CTD screen, Thermo Fisher)
Lone Nørgård Troelsen, Søren Jacobsen, Lina Pedersen
P28
Measuring gamma-H2AX as a biomarker for DNA damage after ionizing radiation
treatment in cancer patients
Pegah Johansson, Aida Muslimovic, Ragnar Hultborn, Erik Fernström, Ola Hammarsten
P29
Novel Circulating isoforms of hepcidin
Morten Moe, Tor-Arne Hagve, Ingrid M. Hardang
P30
Early diagnosis and calculating the risk of ovarian cancer in women by combining the
results of two biomarkers HE4 & CA125
Aaso Raoofi, Adam Molner, Fereshteh Pourlotfi, Tatyana Danylchenko
Hematology
P31
Assessment of a diagnostic algorithm to classify von Willebrand disease
Karin Littmann, Maria Berndtsson, Eva-Marie Norberg, Jovan Antovic
P32
Trypan Blue accurately defines the viability of CFU-GM cells in Cord Blood Units
Sofia U. Frändberg, Eva Anghem, Inger Ögärd, Lars Palmqvist
P33
Exploring the heterogeneity of the hematopoietic stem cell pool: A simultaneous ­staining
protocol for the Side population, Aldehyde dehydrogenase and CD34 in Cord Blood
Sofia U. Frändberg, Susann Li, Cecilia Boreström, Lars Palmqvist
P34
Are hemoglobin variants eluting in “variant window” on Bio-Rad Variant Turbo 2.0
affecting the HbA1c results?
Britta Landin, Lena Fredriksson
P35
The usefulness of the “Imm Gran?” flag reported on by the Sysmex XE-5000
Heidi Eilertsen, Tor-Arne Hagve
P36
Hypersegmentation in a routin laboratory– a common finding or not?
Anna Maj Ericsson, Helena Orre-Ekdahl, Stefan Jacobsson
P37
Evaluation of ‘CellaVision Advanced RBC application’; new software for reporting
­erythrocyte morphology
Eva Grönlund, Margit Döry, Agnetha Evers, Soheir Beshara
P38
Interference of Monoclonal Antibody Therapies with Serum Protein Electrophoresis Analysis
Claus Brasen, Jakub Krejcik, Torben Plesner
P39
Whole exome sequencing of sorted leukemic cells as a complementing method in genetic
­characterization of acute myeloid leukemia
Erik Malmberg, Sara Ståhlman, Sofie J. Alm, Tore Samuelsson, Lars Palmqvist, Linda Fogelstrand
15
Point of care testing
P40
Evaluation of HemoCue WBC DIFF system versus Sysmex XE in blood samples from
pediatric patients
Anette Friis Larsen, Ole Halfdan Larsen, Anne Dorthe Møller, Søren Ladefoged, Tore Hardlei
P41
Harmonizing POCT and Central Core Laboratory analyzers
Anne-Charlotte Wicktorsson, Maria Thornemo
P41:2
Assuring quality in point-of-care testing at the Sahlgrenska University Hospital
Anne-Marie Johannesson, Ingrid Uttberg, Maria Thornemo
P42
Centralized vs. decentralized blood collection: A comparison of quality indicators for
the p
­ reanalytical phase
Erik K. Amundsen, Solrun Fransen, Gro Siri B. Lillesund, Tonje V. Larsen, Karin Toska
P43
Like Herding Cats – Information Technology Facilitates Management of Point of Care
Testing Systems
Nicole Carney, Robert Dodds, Katrina Moreau, Gregory Sharp
P44
Evaluation of three different CRP Point of Care Testing instruments
Slavena Mandic, Marie Palmblad, Laura Goobar Larsson
Laboratory education
P45
Clinical chemistry practice in Republic of Macedonia
Jasna Bogdanska, Danica Labudovic
Novel company technology
P46
Keeping Bacteria Under Control to Minimize Impact on Assays and Maximize Analyzer Uptime
Stephane Mabic, Maryse Gauthey Baraou, Johan Thorell
Other
16
P47
Integrated EQA
Jonna Pelanti, Samuli Niiranen
P48
Method comparison of three automated 25-hydroxy vitamin D enzyme immunoassays
to l­iquid chromatography tandem mass spectroscopy (LCMS/MS) and against each other
Nada Rakovan, Trine Lauritzen, Per O. Nordstrøm, Øyvind Skadberg
P49
Automated alarm to detect antigen excess in serum free immunoglobulin light chain
kappa and lambda assays – Experience from routine application
Karin Toska, Erik K. Amundsen, Petter Urdal, Olav Klingenberg
P50
Haemolysis in underfilled venipuncture testtubes
Birgitta Gren
P51
Reproducibility problem in an ELISA assay method – fibroblast growth factor 23 (FGF-23)
as an example
Henrik Alfthan, Helene Markkanen, Esa Hämäläinen
P52
Efficient extraction of human DNA from stool samples and detection of genetic and
­epigenetic alterations specific for colorectal neoplasia
Aleksandra Mandic Havelka, Annelie Strålfors, Lars-Olof Hansson, Ulrik Lindfors, Gösta Eggertsen
P53
PAPP-A2. Median values in normal pregnancy in first trimester and association to
Small-For-Gestational-Age infants
Young Bae Hansen, Vibeke Myrhøj, Finn S. Jørgensen, Claus Oxvig, Steen Sørensen
P54
Comparison of two methods for determination of coagulation factor VIII activity
Susanne Samuelsson
P55
Evaluation of Technopath Controls on the ARCHITECT Family of Instruments
Jessie Shih, Didier Brault, Antonio Croce, Lieselotte Lennartz, Matthias Orth
P56
Comparison of the results of immunoglobulin (IgA,IgG,IgM), IgG subclasses and
specific ­antibodies of patients with frequent sinopulmonary problems
Elo Saue
P57
Clinical chemical monitoring of PFIC-patients treated with a new surgical method
Karin Littmann, Cecilia Gälman, Paolo Parini, Björn Fishler, Antal Nemeth, Eva Beijer,
Maria M
­ agnusson, Ronald Oude-Elferink, Gösta Eggertsen
P58
Hidden asymptomatic CDG cases may be mistaken for excessive alcohol consumption
Anders Helander, Jaak Jaeken, Gert Matthijs, Gösta Eggertsen
P59
Up-regulation of Liver Enriched Transcription Factors (HNF4a and HNF6) and Liver ­Specific
MicroRNA (MiR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells
Nosratollah Zarghami, Effat Alizadeh, Abolfazl Akbarzadeh, Mohamadreza Baghaban Eslaminejad,
Kazem Nejati-Koshki
P60
Kidney stone analysis by FTIR
Morten Moe, Marianne Moe, Gunnhild Kravdal
P61
Sigma metrics used to assess analytical quality of clinical chemistry assays: Importance
of the allowable total error (TEa) target
Dave Armbruster, Sten A. Westgard
P62
Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression
in the T47D Breast Cancer Cell Line – Results of Real Time Quantitative PCR
Faraz Zarghami, Abolfazl Akbarzadeh
P63
Effect of rest time prior to blood sampling on common biochemical parameter – results
from thyreotropin
Ida B. Andersen, Claus L. Brasen, Lene Nohr-Jensen, Dorthe E. Nielsen, Jonna S. Madsen
P64
Serum 25-hydroxyvitamin D below 75 nmol/L observed in 75% of healthy Swedish audults
­during 75% of the year
Göran Oleröd, Eva Klingberg, Jan Konar, Max Petzold , Ola Hammarsten
P65
Effect of apixaban on common coagulation analyses
Inger Fagerberg Blixter and Equalis
17
Author index
A
Aggerholm, Anni
316, P316
Beijer, Eva
P57
Akbarzadeh, Abolfazl
P11, P59, P62
Bellosillo, Beatriz
316, P316
Alabakovska, Sonja
P01
Benedek, Peter
223, P223
P12
Bergo, Martin O.
103
Alfthan, Henrik
P51
Berndtsson, Maria
P31
Alizadeh, Effat
P59
Beshara, Soheir
P37
Alm Johansson, Sofie
P39
Bjurman, Christian
414, P414
Almås, Bjørg
317
Blennow, Kaj
306, P14, P15
Altamura, Sandro
302
Bogdanska, Jasna
P01,P45
Amundsen Koldberg, Erik
P42, P49
Borén, Jan
101
Andersen Boegh, Ida
P63
Boreström, Cecilia
P33
Andersen Tolstrup, Morten
316, P316
Boudry, Pascal
217, P217
Andréasson, Björn
315, P315
Brandslund, Ivan
P17, P18
316, P316
Brasen Lohmann, Claus
P63
223, P223
Brasen, Claus
P18, P38
P32
Brault, Didier
P55
P31
Brismar, Kerstin
P26
205, P205
Brody, Ed
218, P218
410, P410
Bryon, Jane
316, P316
Armbruster, Dave
P61
Burthem, John
304
Ärnlöv, Johan
203,413, P413
Asin Cayuela, Jorge
222, P222
Asp, Julia
315, P315,
316, P316
Carlsson, Lena
P05
Carney, Nicole
P43
Axelson, Magnus
P26
Cassinat, Bruno
316, P316
Ayala, Rosa
316, P316
Chaudhari, Ravindra
205, P205
Christensen Kjeldahl, Cramer
P17
Christensen, Henry
P17
Christensen, Monika H.E.
317
Colpi, Giovanni M
P02, P03, P20
Corsi Romanelli, Massimiliano M
P02, P03, P20
Coudoré, François
213, P213
Croce, Antonio
P55
Albrethsen, Jakob C.
Andrikovics, Hajnalka
Angelin, Bo
Anghem, Eva
Antovic, Jovan
Antwi, Kwasi
Arendt, Johan Frederik Berg
B
Baghaban Eslaminejad,
Mohamadreza
Barassi, Alessandra
18
P59
P02, P03, P09,
P10, P19, P20
Barron, Jeffrey
P16
Bauer, Timothy
218, P218
C
G
D
Damele, Clara Anna Linda
P02, P10, P20
Gauthey Baraou, Maryse
P46
Danylchenko, Tatyana
P30
Ghilardi, Francesca
P09, P10
Dicker, Frank
316, P316
Girodon, François
316, P316
Distante, Sonia
P21
Gomez Toledo, Alejandro
412, P412
Dodds, Robert
P43
Goobar Larsson, Laura
P44
Duvefelt, Kristina
223, P223
Green, Anders
P17
Döry, Margit
P37
Gren, Birgitta
P06, P50
Grubb, Anders
411
Grönlund, Eva
P37
E
Eggertsen, Gösta
P52, P57, P58
Gustafsson, Carina
P06
Eide, Lars
P21
Gyllensten, Ulf
401
Eilertsen, Heidi
P35
Gälman, Cecilia
P57
Ericsson, Anna Maj
P36
Eriksson Boija, Elisabet
206
Eriksson, Mats
223, P223
Hadlow, Narelle
P23
Ernberg, Ingemar
407
Hagve, Tor-Arne
P29,P35
Estan, Nuria
217, P217
Hammarsten, Ola
Evers, Agnetha
P37
414, P414, P06,
P08, P28, P64
Hanlon, David
308
Hansen, Young Bae
P53
P52
F
H
Fagerberg Blixter, Inger
P65
Hansson, Lars-Olof
Fahlen, Eva
P04
Hansson, Ulrika
315, P315
Farkas Körmendiné, Dóra
410, P410
Hardang, Ingrid M
P29
Fellmann, Mark
305, P305
Hardlei, Tore
P40
Fernström, Erik
P28
Hardy, John
221
Finazzi, Dario
303
Hasselbalch, Hans
313
Fishler, Björn
P57
Hasselbalch, Hans Karl
316, P316
P09
Heegaard, Niels
307
P39
Helander, Anders
P58
P42
Helmersson-Karlqvist, Johanna
413, P413, P07:2
P34
Hermouet, Sylvie
316, P316
P06
Herrera, Catherine
P25
P40
Hesse, Camilla
404
P13
Høie, Kari
P21
P32, P33
Hornung, Nete
406
414, P414
Hultborn, Ragnar
P28
Flaminio, Alessandra
Fogelstrand, Linda
Fransen, Solrun
Fredriksson, Lena
Friden, Jan
Friis Larsen, Anette
Frikke-Schmidt, Ruth
Frändberg, Sofia Ulrika
Fu, Michael
19
317
Hämäläinen, Esa
P51
Labudovic, Danica
P01, P45
Höök, Fredrik
214
Ladefoged, Søren
P40
Laitinen, Päivi
403
Landegren, Ulf
209
I
Iapichino, Gaetano
P10
Landin, Britta
P34
Ivanov, Agnes
P22
Langenstam, Erika
P04
Larsen Versvik, Tonje
P42
Larsen, Ole Halfdan
P40
J
Jacobsen, Søren
P27
Larson, Göran
412, P412
Jacobsson, Stefan
P36
Larsson, Anders
Jaeken, Jaak
P58
413, P413, P05,
P07:2
Jerjomina, Jelena
P24
Lauritzen, Trine
P48
Johannesson, Anne-Marie
P41:2
Leber, Amanda
205, P205
Johansson, Pegah
P08, P28
Lefèvre, Guillaume
217, P217
Johansson, Peter
315, P315
Leibundgut Oppliger, Elisabeth
316, P316
Johnsen, Anders H.
P12
Lemonnier, Alban
213, P213
Jørgensen, Finn Stener
P53
Lennartsson, Ann-Britt
305, P305
Jovanova, Silvana
P01
Lennartz, Lieselotte
217, P217,P55
Jürs, Martina
310
Lewandowski, Krzysztof
316, P316
Li, Susann
P33
Lien, Ernst A.
317
K
20
L
Hustad, Steinar
Kallberg, Birgitta
208, P14, P15
Lillesund Birkeland, Gro Siri
P42
Karabasic, Erika
P04
Lindahl, Anders
211, P211,322
Kere, Juha
223, P223
Lindahl, Bertil
201
Kiernan, Urban
205, P205
Lindahl, Per
103
Kinalis, Joannis
P04
Linde, Malin
223, P223
Kjær, Lasse
316, P316
Lindfors, Ulrik
P52
Kjellström, Birgitta
222, P222
Lindgren, Julia
222, P222
Klingberg, Eva
P64
Lippert, Eric
316, P316
Klingenberg, Olav
P49
Littmann, Karin
P31,P57
Konar, Jan
P64
Lodé, Laurence
316, P316
Krastins, Bryan
205, P205
Lopez, Mary
205, P205
Kravdahl, Gunnhild
P25, P60
Lotz, Johannes
217, P217
Krejcik, Jakub
P38
Lovestone, Simon
312
Krintus, Magdalena
217, P217
Lönnquist, Maria
P15
Kristensen Kielsgaard, Thomas
316, P316
Löwbeer, Christian
405
Kubista, Mikael
210
Köller, Ursula
217, P217
M
Mabic, Stephane
P46
Madsen Skov, Jonna
P63
Maegaard, Christian Ulrik
P18
Magnusson, Maria
P57
Nilsson, Åsa
222, P222
Malmberg, Erik
P39
Nilsson, Jonas
412, P412
Malmgård, Gisela
P14
Nilsson, Maria
212, P212
Mandic Havelka, Aleksandra
P52
Noborn, Fredrik
412, P412
Mandic, Slavena
P44
Nohr-Jensen, Lene
P63
Markkanen, Helene
P51
Nomdedéu, Josep
316, P316
Marotta, Roberta
P09
Norberg, Eva-Marie
P31
Marusic, Maruska
316, P316
Nordestgaard, Børge G
P13
Mathew, Sherin
P08
Nordstrøm, Per Olov
P48
Matthijs, Gert
P58
Norlén, Anna-Karin
212, P212
Matussek, Andreas
320
Nybo, Mads
217, P217
Mehler, Bob
218, P218
Melander, Olle
202
Melzi D'eril, Gianvico
P02, P03, P09,
P10, P19, P20
Ohlsson, Claes
212, P212
Oleröd, Göran
P64
Mindemark, Mirja
309
Oliva Torstensson, Oscar
P06
Moe, Marianne
P60
Orre-Ekdahl, Helena
P36
Moe, Morten
P29,P60
Orth, Matthias
P55
Mogensen, Nina
P18
Oude-Elferink, Ronald
P57
Molina, Rafael
408
Oxvig, Claus
P53
Møller, Anne Dorthe
P40
Møller, Holger Jon
319
Molner, Adam
P30
Pallisgaard, Niels
316, P316
Monserrat, Lorenzo
220
Palmblad, Marie
P44
Moreau, Katrina
P43
Palmqvist, Lars
Mørkrid, Lars
P21
315, P315, P32,
P33, P39
Muslimovic, Aida
P28
Pancrazzi, Alessandro
316, P316
Myrhøj, Vibeke
P53
Paolo, Arosio
303
Månsson, Jan-Eric
222, P222
Parini, Paolo
P57
Möckel, Martin
215
Pedersen, Lars
410, P410
Pedersen, Lina
P27
Pelanti, Jonna
P47
N
O
P
Naguib, Dina
316, P316
Percy, Melanie
316, P316
Nejati-Koshki, Kazem
P59
Peterman, Scott
205, P205
Nellgård, Bengt
P15
Petersen Hyltoft, Per
P17
Nemeth, Antal
P57
Pettersson, Tom
402
Nexø, Ebba
301,410, P410
Petzold, Max
414, P414, P64
Niederkofler, Eric
205, P205
Pezzilli, Raffaele
P02, P03, P19, P20
Nielsen Elkjaer, Dorthe
P63
Pikta, Marika
P22, P24
P17
Plebani, Mario
217, P217
318
Plesner, Torben
P38
P47
Pourlotfi, Fereshteh
P30
P25
Prakash, Amol
205, P205
Nielsen, Aneta Alexandra
Niemelä, Onni
Niiranen, Samuli
Nilsen, Malene
21
R
Thornemo, Maria
P41, P41:2
Rakovan, Nada
P48
Tivesten, Åsa
212, P212
Randall, Jeffrey
P14
Tosheska Trajkovska, Katerina
P01
Raoofi, Aaso
P30
Toska, Karin
P42,P49
Rasmussen, Katrine Laura
P13
Troelsen, Lone Nørgård
P27
Ryberg, Henrik
212, P212
Tubbs, Kemmons
205, P205
Tybjærg-Hansen, Anne
P13
Tyynismaa, Henna
219
S
Salomo, Morten
P12
Samuelson, Emma
222, P222,
316, P316
Umbrello, Michele
P10
Samuelsson, Susanne
P54
Urdal, Petter
P49
Samuelsson, Tore
P39
Uttberg, Ingrid
P41:2
Sandberg, Sverre
207
Saue, Elo
P56
Sayin, Volkan
103
Vandenput, Liesbeth
212, P212
Schnittger, Susanne
314
Venge, Per
204
Schroeder, Tara
205, P205
Viia, Vaike
P07
Schwarz, Jiri
316, P316
Viigimaa, Iige
P24
Seyyed Khezri, Banafsheh
P05, P07:2
Viktil, Jørgen
321
Shahim, Pashtun
P14
Vorland, Marta
316, P316
Sharp, Gregory
P43
Shih, Jessie
217, P217, P55
Siegbahn, Agneta
216
Wardrop, Robert
P23
Simonsson, Per
311
Wasslavik, Carina
315, P315
Singer, Britta
218, P218
Westgard, Sten Anders
P61
Skadberg, Øyvind
217, P217, P48
Wicktorsson, Anne-Charlotte
P41
Skinnes, Ragnhild
P21
Williams, Stephen
218, P218
Smith, Geoff
P16
Wilson, David H
P14
Sørensen Toft, Henrik
410, P410
Wold, Agnes
102
Sørensen, Steen
P53
Ståhlman, Sara
P39
Stefanelli, Rossana
P02,P10,P20
Zarghami, Faraz
P62
Sterling, David
218, P218
Zarghami, Nosratollah
P59
Strålfors, Annelie
P52
Zemtsovskaja, Galina
P22,P24
Sundfeldt, Karin
409
Zetterberg, Henrik
P14,P15
Tegner, Yelverton
P14
Ärnlöv, Johan
Thibert, Valérie
213, P213
Thomsen, Carsten
P18
Thorell, Johan
P46
T
22
U
V
W
Z
Ä
Ö
Ögärd, Inger
P32
Roche Diagnostics Seminars
Program
Wednesday, September 17
8:30-9:00
(Booth)
The value of NT-proBNP in the monitoring
and treatment of heart failure patients
Åke johansson M.D. Specialist Allmänmedicin
Askim Vårdcentral Göteborg
Thursday, September 18
8:30-9:00
(Booth)
New hematology instruments from Roche cobas m511 (Bloodhound technology)
Mark Fellmann Ph.D., Int Produktchef Hematologi
Roche
9:45-10:15 The value of NT-proBNP in the monitoring
(Booth)
and treatment of heart failure patients
Åke johansson M.D. Specialist Allmänmedicin
Askim Vårdcentral Göteborg
9:45-10:15 New hematology instruments from Roche (Booth)
cobas m511 (Bloodhound technology)
Mark Fellmann Ph.D., Int Produktchef Hematologi
Roche
11:30-12:00 Evaluation of the CoaguChek XS for analysis
(Booth)
of PK(INR) taken by capillary sampling
Maria Tornemo M.D.Ph.D., Annika Björk Leg. BMA
Klinisk Kemi Sahlgrenska Universitetsjukhuset
10:15-11:30 The future clinical laboratory as diagnostic
(Conference partner
program) Mirja Mindemark, PhD, Senior Account Manager,
Roche Diagnostics Scandinavia AB
12:30-13:00 Evaluation of the CoaguChek XS for analysis
(Booth)
of PK(INR) taken by capillary sampling
Maria Tornemo M.D.Ph.D., Annika Björk Leg. BMA
Klinisk Kemi Sahlgrenska Universitetsjukhuset
12:30-13:15 Lunchseminarium,
(F1)
Paneldebatt med fokus på hur sjukvården
14:45-15:15 High-sensitivity troponin T provides faster
(Booth)
and better care for chest pain
Dina Melki M.D., Ph.D.
Avd för Kardiologi Karolinska Universitetssjukhuset
14:45-15:15 S100B; Biomarker in new guidelines for
(Booth)
traumatic brain injury
Eric elin, M.D., Ph.D.-doktorand
Avd. för Neurokirurgi Karolinska Universitetssjukhuset
kan dra mer nytta av laboratoriemedicin
Friday, September 19
9:45-10:15 S100B; Biomarker in new guidelines for
(Booth)
traumatic brain injury
Eric elin, M.D., Ph.D.-doktorand
Avd. för Neurokirurgi Karolinska Universitetssjukhuset
23
Guidelines for Speakers
The Speakers Preview Room is located outside Room 1. Speakers are kindly requested
to provide their PC-formatted USB keys (PowerPoint presentations) to the staff in the
Speakers room, preferably the day before, or at least 2 hours prior to the presentation.
The lecture room is equipped with data projection equipment. File format: Microsoft Power
Point or Adobe Acrobat formatted for Windows (PC). Preferred Resolution: XGA (1024 x 768)
Technical staff will be available
in the Conference room as follows:
Tuesday 16th 11.00 –15.30
Wednesday–Thursday 17th & 18th 07.30–16.30
Friday 19th 08.00–11.30
!
Good to know
Prepare your presentation in good time.
If you have film sequences in your presentation be sure that they function when
you have transferred them into the NFKK computer system.
In respect to Your fellow Oral Presenters be at the first row seats 15 minutes prior
to the start of Your session and announce Your presence to the Chairman of
Your session.
24
WE ARE SHARING OUR
KNOWLEDGE – JOIN US!
“Better staining. Better diagnostic morphology. Three Ways.”
Thursday 18 September 12:30 – 13:15, Meetingroom F2
Come visit us
at booth #14 and
win an iPod nano* !
We pride ourselves on being a knowledge-based company and enjoy sharing
our know-how. So you can truly make the most of our products, technology
and services. And, perhaps, even better serve your customers.
“Better staining. Better diagnostic morphology. Three Ways.”
Thursday 18 September 12:30 – 13:15, Meetingroom F2
We look forward to seeing you there. Of course there will be time for
a Q&A session afterwards.
Sysmex Sverige
www.sysmex.se
Shaping the Advancement of Healthcare
*
So why not take some time out from your busy schedule to brush up on some
of our latest insights and enjoy a tasty lunch? We think you’ll appreciate it …
iPod nano is a trademark of Apple Inc.
This year at the XXXIV Nordic Congress in Clinical Chemistry, Gothenburg,
Sweden, we are holding a lunch symposium – given by one of our experts
within Laboratory Solutions.
Social Program
Welcome Reception
Tuesday, September 16th, 15:15
Immediately after the last session this day a Welcome Reception will be held in the exhibition
area. The reception is hosted by the City of Göteborg and the Region of Västra Götaland.
Participation is included in the congress fee but must be reserved in advance through the
online registration system to obtain a ticket.
Glitter and Glamour Banquet
Thursday, September 18th, 19:30
Estrad Restaurant, Mässans gata 5. Entrance 5
Come and join colleagues and new friends!
The Congress Banquet with the theme,
“Glitter & Glamour” will be held in the
Estrad Restaurant, one of the restaurants
in the Congress Centre.
We will start with a drink at “Bryggan” located
on the first floor, directly above our entrance.
We then proceed along the “red carpet” to
the ­Estrad Restaurant where a delicious three
course dinner will be served.
During this evening, the winners of the Astrup
prizes and the recipients of the Eldjarn prizes
will be announced. The “Glitter Girls” Jamladies
will entertain us followed by a Dj and dancing.
Participation is not included in the congress fee.
Price SEK 700.
26
Jamladies are three well experienced artists
who will give your evening that little extra
when it comes to glitter and glamour. With
fancy costumes, beautiful voices and a warm
and charming appeal Jamladies will create a
show you will never forget.
Congress Information
Abstracts
All abstracts will be available in an abstract database on the web site www.nfkk2014.se
You can search for abstracts in several different ways; browse author index and session
programme indices (orals and posters) or free text search. Badge
Participants will receive their name badges at the conference registration desk. Since only
registered participants will be permitted to attend the scientific sessions, the exhibition and
poster areas, you are kindly requested to wear your badge when entering the congress venue.
Please note that admission to scientific sessions is strictly restricted to participants wearing
their badges. Exhibitors without a full congress registration are not entitled to attend the
scientific sessions. Lost badges can be replaced at the registration desk. However, a handling
fee will be charged.
Cloak room
There is an unattended cloak room in the exhibition are.
Coffee breaks and luncheon
Refreshments will be served free of charge in the exhibition area.
Congress Web site
In time for the congress we will rearrange www.nfkk2014.se to focus on the information you
need when you are on site. The site will also be optimised for portable units to fit nicely on
your smartphone or tablet. The Daily News is produced by our editorial on site, follow it on our
big screen or on nfkk2014.org
On site Registration
Registration Desk Opening Hours
Tuesday 16th................................................11.00–15.30
Wednesday–Thursday 17th & 18th...........07.30–16.30
Friday 19th...................................................08.00–12.00
On-site registration is accepted but
participation in the social events at
that time may be severely limited. Exhibition Opening Hours
Tuesday 16th................................................11.00–18.00 (Welcome reception 15.15–18.00)
Wednesday 17th.........................................09.30–16.30
Thursday 18th.............................................09.30–16.30
Friday 19th...................................................09.30–12.00
27
General Information
Credit cards
Commonly accepted credit cards in hotels, restaurants and shops and at the conference
­registration desk are American Express, Diners Club, Visa, Master Card and Euro card.
Restaurants and shops generally display signs indicating what cards they accept.
Currency
The local currency is the Krona (pl. kronor). 1 krona = 100 öre. Approximate exchange rate:
1 EUR = 9.15 SEK. Most banks, the manned ones, can exchange foreign currency. Credit
cards are widely accepted in Sweden and the exchange rate is usually better than for cash
or travellers cheques. It is advisable to find out what the commission is before proceeding
with the transaction.
Electricity
Sweden uses 230-volt AC, 50Hz current. Visitors will need an adaptor for electric appliances,
whereas North Americans need a transformer.
Emergency numbers
For all emergencies, please dial 112.
Internet
There is WIFI access in the exhibition area. Use the net work NCCC2014 and login NCCC2014
to go on line.
Insurance
Neither the Conference Organisers or the Conference Secretariat accept any liability for
­personal injuries sustained, or for loss or damage to property belonging to conference
participants, either during or as a result of the conference.
Language
The official conference language is English. There will be no simultaneous translation.
Swedish is the official language in Sweden. English is common in hotels and tourist places
and is also spoken by most Swedes.
28
Foto: Kjell Holmner
Foto: Kjell Holmner
Public transportation
Gothenburg has a very modern and efficient public transportation network which includes
an elaborate tramway system, buses, and ferries. The city has over 200 trams, covering 11
different routes, all of which connect to other forms of transport. Gothenburg also bills itself
as having “the world’s most modern public transportation system”, with electronic signs at
all tram, bus, and ferry stops telling passengers exactly when the next one is coming and
­notifying riders of any traffic snarls in the system.
The information posted on the trams and stops is in Swedish only, so you should have a
good idea of how the trip should go before starting. www.vasttrafik.se/en
From Landvetter Airport to the Congress Centre
Gothenburg-Landvetter Airport – main international airport – is located 20 km to the east of
Gothenburg. Airport buses are running frequently between Gothenburg and the airport. Take
the airport bus (SEK 90 = approx. EUR 9) or taxi to Korsvägen (SEK 450 = approx. EUR 50) –
opposite The Swedish Exhibition Centre´s main entrance.
From City Airport (Säve Airport) to the Congress Centre
Gothenburg City Airport is located 8 km to the north of Gothenburg. Buses run every 20
­minutes between the airport and Gothenburg Central Station. Stop at Nils Ericssonsplatsen/
Central Station.
Change to tram (see below). The trip takes 35 minutes. A taxi fare between the airport
and the City Centre is approximately SEK 400 (around EUR 45).
From Gothenburg Train Central Station by tram
Take tram No. 4, 13 or 14. From nearby Brunnsparken, you can take tram No. 4 or 5. The
trams stop at Korsvägen, just opposite Svenska Mässan and Gothenburg Convention Centre.
29
Foto: Bernstone Fotografi
Foto: Kjell Holmner
Tram
Gothenburg has the largest tram network in Europe. Taking the tram is one of the nicest ways
of getting around in Gothenburg. The city has 204 trams which operate 11 routes, as well as
buses and archipelago ferries.
The Älvsnabben ferry provides services along the harbour. The journeys are included in
the same public transport ticket. The easiest way is to buy tickets in advance from Tidpunkten
or Pressbyrån shops. The Gothenburg’s City Pass, available from all tobacconists allows unlimited use of the city’s excellent tram and bus system. You can also buy your ticket directly on
the bus or tram.
Shopping
Department stores and most shops are open from:
Monday–Friday....................................... 09:30–18:00
Saturday.........................................09:30–13:00/16:00
Sunday (department stores)....................12:00–16:00
In Sweden, many convenience stores (“närbutiker”) are open 07:00–23:00
in major cities, such as Stockholm, Gothenburg and Malmö.
30
Foto: Kjell Holmner
Foto: Lars Ardarve
Taxis
The concierge of your hotel can call a taxi for you, or you may want to call the following
taxi companies:
“Taxi Göteborg”: +46 (0)31 650 000 or “Taxikedjan” +46 (0)911-922 66.
Gothenburg’s taxis are one way of getting around in the city, although the meter ticks
away alarmingly when you are stuck in the rush hour traffic. You can share the front seat
with the driver if you wish.
There is an initial charge when starting the journey. There is a slightly higher rate per
­kilometre if leaving the city limits. If you pay by credit card, it is necessary to inform the
driver in advance.
Note! There are a lot of so called “Svart taxis” in Gothenburg. That means a person
­driving an ordinary car without a taxi license. Usually they come up to you asking you
if you would like a “Svart taxi”. We do not recommend you to take these taxis.
Smoking policy
No smoking will be permitted at any time inside the conference venue. Smoking is banned
on public transport, in stores, restaurants and pubs. Hotels offer special rooms for non
smokers. Please indicate your request on the registration form, when you make your hotel
reservation.
Time zone
Sweden is one hour ahead of Greenwich
Mean Time (GMT).
31
Foto: Bernstone Fotografi
Foto: Jorma Valkonen
Tourist information
For tourist information about Gothenburg, Sweden, please visit the website: ­
www.goteborg.com.
VAT
The standard VAT rate in Sweden is 25%. Everybody who visits Sweden as a tourist
and who is not a resident of an EU country is eligible for the VAT reimbursement
(More information at www.globalrefund.com).
Note that value added tax in Sweden is almost always included in the price that is ­
indicated in shops.
Visitors from outside the European Union are able to reclaim the VAT on goods purchased,
either at the airport or at the border. Look for the tax-free sign in shops and please remember
to ask for the VAT reclaim form at the time of the purchase. Global Refund Sverige has around
15’000 affiliated shops and department stores. Minimum purchase is 200 SEK. When
­purchasing the goods, a Global Refund Cheque is issued and your items are sealed. The
Global Refund Cheque can be cashed upon departure from the EU at any exit point – ports,
ferry t­ erminals, airports, border crossings, etc. The cheque is valid during the month of
­purchase and during the 3 following months. For additional information, please contact:
Global Refund Sverige E-mail: taxfree@se.globalrefund.com
Venue
Svenska Mässan (The Swedish Exhibition & Congress Centre) in Gothenburg
Visitor´s addresse: Mässans Gata 2, Entrance 2.
32
2014H-017A
Today’s well-being is
tomorrow’s greatest resource.
Siemens answers are creating an impact on human
health that will last generations.
siemens.se/healthcare
The healthier people are today, the
better the world will be tomorrow.
That’s because long, healthy lives
make it possible for people to give
their best. And build a happier world
for today’s generations and generations to come. That’s why Siemens
works to advance human health, with
answers that last. We’re helping
clinicians and hospitals expand
access to care while cutting costs, so
they can better care for a growing
world. We’re creating innovations that
will have a lasting impact, so an aging
population can continue to be a
healthy one. We believe that, like every
precious resource on earth, human
health should be cherished, sustained.
Not just for today, but for the promise
of a better tomorrow.
Answers for life.
Our Exhibitors
Exhibitor
Stand No
Abbott Scandinavia AB ACC NordiC AB Alere AB AH diagnostics Beckman Coulter AB Bio-Medical Lab Supplies Ltd Bio-Rad Laboratories AB BioMerieux Sweden AB Biotech-IgG AB Exhibitor
12
23
32
22
10
5
3
27
25
Entrance 1
BP
F2
F3
TECH
260 seats
TECH
buffét
buffét
posters
Gång
BP
Triolab
34
posters
Fiomi
33
TECH
250 seats
Cloakroom
Passage to Gothia Towers/
Meeting Rooms
34
26
6
4
24
7
40
8
29
33
Slide Room
Press Room
36
F1
Room
Nordenskiöld
Stand No
CALPRO AS CellaVision CompuGroup Medical Lab AB Dako DiaSorin AB DiaSystem Scandinavia AB Electra-Box Diagnostica AB Euro Diagnostica AB Fiomi Diagnostics AB Tieto
28
Buffét
Roche Diagnostics
13
Siemens
Healthcare
Diagnostics
9
Nordic
Alere
BioSite 30 32
Scantec
39
DiaSystem
40
LGC
37
HaemoMedtech
38
Electra
8
DiaSorin
7
CellaVision
6
Bio-Medical
5
Staff/Storage
35
Stand No
Nordic
Haenostatis
41
Sysmex Sverige
14
Buffét
Thermo Fisher
Scientific
11
Beckman Coulter
10
SERO
19
GATC Biotech AB
17
Haemo Medtec Aps
38
HemoCue 15
IDS Nordic A/S 20
Lab-Tech & Skafte Medlab 1
LGC37
Merck Millipore 21
Nordic BioSite
30
Nordic Haemostasis AB
41
Roche Diagnostics 13
Timedico
18
GATC
Biotec
17
Euro
Diagnostica
29
HemoCue Abbot
15
Scandinavia AB
12
Compu
Group 4
Registration
IDS Nordic
20
Bio Rad
3
Buffét
Lab-Tech Software
1
Point 2
550 platser
daily news
Millipore
21
AH
Diagnostics
22
ACC Nordic
23
DAKO
24
Biotech
25
CALPRO
26
bioMérieux
27
Exhibitor
Exhibitor
Scantec Nordic AB SERO AS Siemens Healthcare Diagnostics Software Point Sysmex Sverige Thermo Fisher Scientific Tieto Sweden Healthcare & Welfare Timedico A/S Triolab AB Stand No
39
19
9
2
14
11
28
18
34
Entrance 2
35
Foto: Dick Gillberg
Foto: Krister Engström
Foto: Liseberg
Operan
Kajskjul 8
Göteborg
Lilla Bommen
Central Station
Ullevi
city
Scandic
Hotel Opalen
n
ny
e
Av
The Swedish Exhibition
& Congress Centre
Götaplatsen
Museum
of Modern Art
Villa Fridolin
Hotel Gothia
Korsvägen
Universeum
Thanks to our
Sponsors and Exhibitors
P latinum sponsors:
ARING OUR
E – JOIN US!
G old sponsor S:
er diagnostic morphology. Three Ways.”
E xhibitors:
ACC NordiC AB, Alere AB, AH diagnostics, Bio-Medical Lab Supplies Ltd, Bio-Rad
­Laboratories AB, BioMerieux Sweden AB, Biotech-IgG AB, CALPRO AS, CellaVision,
CompuGroup Medical Lab AB, Dako, DiaSorin AB, DiaSystem Scandinavia AB,
Electra-Box Diagnostica AB, Euro Diagnostica AB, Fiomi Diagnostics AB, GATC,
HaemoMedtec ApS, IDS Nordic A/S, Lab-Tech & Skafte Medlab, LGC, Merck Millipore,
Come visit us
Nordic Biosite, Nordic Haemostasis AB, Scantec Nordic AB, SERO AS, Software Point,
booth
Tieto Sweden Healthcare & Welfare, Timedicoat
A/S,
Triolab#14
AB and
win an iPod nano* !
Samtliga foton genom Mediabank Göteborg & Co
– 13:15, Meetingroom F2